ERS 2022

COVID-19: What Is New?

Does vilobelimab reduce mortality in severe COVID-19? 

Presented By

Prof. Alexander Vlaar, Amsterdam UMC, the Netherlands

Trial

Phase 3, PANAMO

Conference

ERS 2022

30 October, 2022 20:35

Awake proning not positive in COVID-19

Presented By

Prof. Jason Weatherald, University of Alberta, Canada

Trial

COVI-PRONE

Conference

ERS 2022

30 October, 2022 20:30

Favipiravir may help patients over 60 years with COVID-19 to recover 

Presented By

Dr Christopher Orton, Royal Brompton Hospital, UK

Trial

Phase 3, PIONEER

Conference

ERS 2022

30 October, 2022 20:28

Brensocatib fails in severe COVID-19 

Presented By

Ms Holly Keir, University of Dundee, UK

Conference

ERS 2022

30 October, 2022 20:25

Inhaled agent under investigation for COVID-19 

Presented By

Prof. Tom Wilkinson, University of Southampton, UK

Trial

Phase 3, SPRINTER

Conference

ERS 2022

30 October, 2022 20:22

Accurate voice-based COVID-19 diagnostic test in development

Presented By

Ms Wafaa Aljbawi, Maastricht University, the Netherlands

Conference

ERS 2022

30 October, 2022 20:19

Novel scoring tool for post-COVID syndrome aids clinicians and researchers

Presented By

Prof. Thomas Bahmer, University of Kiel, Germany

Conference

ERS 2022

30 October, 2022 20:16

COPD: Therapies and Innovations

All About Asthma

Tezepelumab in asthma: mucus plugging down, lung function up

Presented By

Prof. Christopher Brightling, University of Leicester, UK

Trial

Phase 2, CASCADE

Conference

ERS 2022

30 October, 2022 21:06

Digital asthma intervention improves health and reduces costs 

Presented By

Mr Luca Ponti, Amiko Digital Health, Italy

Conference

ERS 2022

30 October, 2022 21:03

Digitally enhanced therapy lowers treatment burden and costs in severe asthma 

Presented By

Prof. Richard Costello, Bon Secours Hospital Dublin, Ireland

Trial

INCA-SUN

Conference

ERS 2022

30 October, 2022 21:01

Mepolizumab beneficial for patients with severe eosinophilic asthma 

Presented By

Dr Rupert Jakes, GSK, UK

Trial

REALITI-A

Conference

ERS 2022

30 October, 2022 20:59

Progress in Paediatrics

Antibiotics cause increased risk of wheezing in severe RSV bronchiolitis 

Presented By

Prof. Avraham Beigelman, Schneider Children's Medical Center of Israel, Israel

Conference

ERS 2022

30 October, 2022 21:23

Inhaled corticosteroids useful in preterms with decreased lung function 

Presented By

Prof. Shannon Simpson, Curtin University, Australia

Trial

PICSI

Conference

ERS 2022

30 October, 2022 21:19

Fish oil or vitamin D during pregnancy can prevent croup

Presented By

Dr Nicklas Brustad, University of Copenhagen, Denmark

Conference

ERS 2022

30 October, 2022 21:16

Encouraging results of nintedanib in children with fibrosing ILD 

Presented By

Dr Robin Deterding, Children’s Hospital Colorado, CO, USA

Trial

Phase 3, InPedILD

Conference

ERS 2022

30 October, 2022 21:10

Focus on Interventional Pulmonology

Head-to-head: lung volume reduction surgery vs endobronchial valves 

Presented By

Ms Sara Buttery, Royal Brompton and Harefield NHS Foundation Trust, UK

Trial

CELEB

Conference

ERS 2022

30 October, 2022 21:42

Durable effect of endobronchial valves in severe emphysema 

Presented By

Prof. Gerard Criner, Temple University, PA, USA

Trial

EMPROVE

Conference

ERS 2022

30 October, 2022 21:40

Cone beam CT-guided ENB improves detection of pulmonary nodules

Presented By

Prof. Benjamin Bondue, Université Libre de Bruxelles, Belgium

Conference

ERS 2022

30 October, 2022 21:37

Confirmatory mediastinoscopy not needed in resectable NSCLC

Presented By

Prof. Jouke Annema, Amsterdam UMC, the Netherlands

Trial

MEDIASTrial

Conference

ERS 2022

30 October, 2022 21:30

Sleep and Breathing Disorders

Other Remarkable Research